Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review

被引:39
|
作者
Kamarudin, Muhamad Noor Alfarizal [1 ,2 ]
Sarker, Md. Moklesur Rahman [1 ,3 ]
Kadir, Habsah Abdul [2 ]
Ming, Long Chiau [4 ]
机构
[1] Lincoln Univ Coll, Fac Pharm, Dept Pharmacol, Jalan Stadium SS 7-15, Petaling Jaya 47301, Selangor Darul, Malaysia
[2] Univ Malaya, Inst Biol Sci, Biomol Res Grp, Biochem Program, Kuala Lumpur 50603, Malaysia
[3] State Univ Bangladesh, Dept Pharm, 77 Satmasjid Rd, Dhaka 1205, Bangladesh
[4] Univ Tasmania, Sch Med, Pharm, Hobart, Tas 7001, Australia
关键词
Clinacanthus nutans; Ethnomedicine; Phytochemicals; Anticancer; Anti-inflammatory; Antiviral activity; MEDICINAL-PLANTS; SCORPION ENVENOMATION; CHEMICAL-CONSTITUENTS; CELL-PROLIFERATION; BARLERIA-LUPULINA; OXIDATIVE STRESS; NATURAL-PRODUCTS; UP-REGULATION; ACETYLCHOLINESTERASE; EXTRACT;
D O I
10.1016/j.jep.2017.05.007
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Clinacanthus nutans (Burm. f.) Lindau, a widely used medicinal plant, is extensively grown in tropical Asia and Southeast Asian countries. C. nutans, with its broad spectrum of pharmacological activities, has been traditionally used to treat cancer, inflammatory disorders, diabetes, insect bites, and skin problems, consumed as a vegetable, mixed with fresh juices, in concoctions, and as a whole plant. The present review analyzes the advances in the ethnopharmacology, phytochemistry, pharmacology, and toxicology of C. nutans. In addition, the needs and perspectives for future investigation of this plant are addressed. Aim of the review: This review aims to provide a comprehensive report on the ethnomedicinal use, phytochemistry, pharmacological activities, molecular mechanisms, and nutritional values of C. nutans. The present review will open new avenues for further in-depth pharmacological studies of C. nutans for it to be developed as a potential nutraceutical and to improve the available products in the market. Material and methods: All the available information on C. nutans was collected using the key words "Clinacanthus nutans" and/or "ethnomedicine" and/or "phytochemicals" and/or "anticancer" and/or "anti-inflammatory" and/or "antiviral" through an electronic search of the following databases: PubMed, Web of Science, EMBASE, Cochrane Library, Clinical Trials.org, SciFinder Scholar, Scopus, and Google Scholar. In addition, unpublished materials, Ph.D. and M.Sc. dissertations, conference papers, and ethnobotanical textbooks were used. The Plant List (www.theplantlist.org) and International Plant Name Index databases were used to validate the scientific name of the plant. Results: The literature supported the ethnomedicinal uses of C. nutans as recorded in Thailand, Indonesia, and Malaysia for various purposes. Bioactivities experimentally proven for C. nutans include cytotoxic, anticancer, antiviral, anti-inflammatory, immunomodulatory, antidiabetic, antioxidant, antihyperlipidemic, antimicrobial, and chemotherapeutic (in aquaculture) activities. Most of these activities have so far only been investigated in chemical, cell-based, and animal assays. Various groups of phytochemicals including five sulfur-containing glycosides, eight chlorophyll derivatives, nine cerebrosides, and a monoacylmonogalactosyl glycerol are present in C. nutans. The presence of two glycerolipids, four sulfur-containing compounds, six known flavones, a flavanol, four flavonols, two phytosterols, one polypeptide, and various phenolics and fatty acids largely influences its diverse bioactivities. Numerous reports justify the ethnomedicinal use of C. nutans as an antiviral agent in treating herpes simplex virus and varicella-zoster virus infections and as part of a traditional anticancer anti-inflammatory concoction agent for various inflammatory diseases. C. nutans tea was reported to have a good percentage of carbohydrate, crude protein, minerals, essential amino acids, nonessential amino acids, and essential fatty acids. Acute, subacute, and subchronic toxicity studies demonstrated that oral administration of ethanol and methanol extracts of C. nutans to male Swiss albino mice and male Sprague Dawley (SD) rats, respectively, did not lead to any toxicity or adverse effects on the animal behavior and organs when used in amounts as high as 2 g/kg. Conclusion: The collected literatures demonstrated that, as an important traditional medicine, C. nutans is a promising ethnomedicinal plant with various extracts and bioactive compounds exhibiting multifarious bioactivities. However, it is important for future studies to conduct further in vitro and in vivo bioactivity evaluations systematically, following the standard pharmacology guidelines. It is crucial to elucidate in-depth molecular mechanisms, structure-activity relationships, and potential synergistic and antagonistic effects of multi-component extracts and bioactive constituents derived from C. nutans. Further studies should also focus on comprehensive toxicity that includes long-term effects and adverse effects on target organs of C. nutans and bioactive compounds in correlation with the specific pharmacological effects.
引用
收藏
页码:245 / 266
页数:22
相关论文
共 43 条
  • [1] Antiviral and Immunomodulatory Activities of Clinacanthus nutans (Burm. f.) Lindau
    Lin, Chung-Ming
    Chen, Hsin-Han
    Lung, Chi-Wen
    Chen, Hui-Jye
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [2] A Comprehensive Review on Phytochemistry and Pharmacological Activities of Clinacanthus nutans (Burm.f.) Lindau
    Khoo, Leng Wei
    Kow, Siew Audrey
    Lee, Ming Tatt
    Tan, Chin Ping
    Shaari, Khozirah
    Tham, Chau Ling
    Abas, Faridah
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [3] A Narrative Review on the Phytochemistry, Pharmacology and Therapeutic Potentials of Clinacanthus nutans (Burm. f.) Lindau Leaves as an Alternative Source of Future Medicine
    Chia, Tan Yong
    Gan, Chee Yuen
    Murugaiyah, Vikneswaran
    Hashmi, Syed F.
    Fatima, Tabinda
    Ibrahim, Lazhari
    Abdulla, Mohammed H.
    Alswailmi, Farhan Khashim
    Johns, Edward James
    Ahmad, Ashfaq
    MOLECULES, 2022, 27 (01):
  • [4] Recent Advancement in Anticancer Activity of Clinacanthus nutans (Burm. f.) Lindau
    Lin, Chung-Ming
    Chen, Hsin-Han
    Lung, Chi-Wen
    Chen, Hui-Jye
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [5] Antidiabetic and antioxidants activities of Clinacanthus nutans (Burm F.) Lindau leaves extracts
    Murugesu, S.
    Khatib, A.
    Ibrahim, Z.
    Ahmed, Q. U.
    Uzir, B. F.
    Nik-Yusoff, N., I
    Perumal, V
    Abas, F.
    Saari, K.
    INTERNATIONAL FOOD RESEARCH JOURNAL, 2019, 26 (01): : 319 - 327
  • [6] Changes in phytochemical contents in different parts of Clinacanthus nutans (Burm. f.) lindau due to storage duration
    Raya, Ketaren Bunga
    Ahmad, Siti Hajar
    Farhana, Sanusi Fatin
    Mohammad, Munirah
    Tajidin, Nor Elliza
    Parvez, Anwar
    BRAGANTIA, 2015, 74 (04) : 445 - 452
  • [7] Clinacanthus nutans (Burm. f.) Lindau Ethanol Extract Inhibits Hepatoma in Mice through Upregulation of the Immune Response
    Huang, Danmin
    Guo, Wenjie
    Gao, Jing
    Chen, Jun
    Olatunji, Joshua Opeyemi
    MOLECULES, 2015, 20 (09): : 17405 - 17428
  • [8] Phytochemistry, Ethnopharmacological Uses, Biological Activities, and Therapeutic Applications of Cassia obtusifolia L.: A Comprehensive Review
    Ali, Md Yousof
    Park, Seongkyu
    Chang, Munseog
    MOLECULES, 2021, 26 (20):
  • [9] Evaluation of cytotoxic and apoptotic activities of Clinacanthus nutans (Burm. f.) Lindau leaves against D24 human melanoma cells
    Fong, Siat Yee
    Wimalasiri, Dilani
    Piva, Terrence
    Dekiwadia, Chaitali
    Urban, Sylvia
    Tien Huynh
    JOURNAL OF HERBAL MEDICINE, 2019, 17-18
  • [10] Volatile Profiling Aided in the Isolation of Anti-Proliferative Lupeol from the Roots of Clinacanthus nutans (Burm. f.) Lindau
    Cheng, Angelina Ying Fang
    Teoh, Peik Lin
    Jayasinghe, Lalith
    Cheong, Bo Eng
    PROCESSES, 2021, 9 (08)